Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT04362839	TitleRegorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2020-04-27	Ubicación California, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Ipilimumab, Nivolumab, Regorafenib, Opdivo, Stivarga, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT04332653	TitleNT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors	Fase Fase 1	Date Added 2020-04-03	Ubicación Florida, United States Michigan, United States Missouri, United States North Carolina, United States Pennsylvania, United States Tennessee, United States Texas, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas NT-I7, Pembrolizumab	Etiquetas MSS/ MMRp
NCT ID NCT04262687	TitleChemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate	Fase Fase 2	Date Added 2020-02-10	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab, capecitabine, oxaliplatin, Pembrolizumab	Etiquetas MSS/ MMRp
NCT ID NCT04185883	TitleSotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)	Fase Fase 1	Date Added 2019-12-04	Ubicación Arizona, United States California, United States Colorado, United States Connecticut, United States Florida, United States Georgia, United States Illinois, United States Indiana, United States Iowa, United States Maryland, United States Michigan, United States Missouri, United States New York, United States North Carolina, United States Ohio, United States Oregon, United States Pennsylvania, United States South Carolina, United States South Dakota, United States Tennessee, United States Texas, United States Utah, United States Virginia, United States Washington, United States Australia Austria Bélgica Canadá Alemania Italia Japón Corea, República de Países Bajos España Taiwán Reino Unido	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas afatinib, AMG 404, Atezolizumab, carboplatin, pemetrexed, docetaxel, everolimus, FOLFIRI, FOLFOX, MVASI® (bevacizumab-awwb), palbociclib, panitumumab, Pembrolizumab, RMC-4630, Sotorasib, TNO155, Trametinib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04130854	TitleINNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer	Fase Fase 2	Date Added 2019-10-18	Ubicación Arizona, United States North Carolina, United States Oregon, United States Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and Radiation Therapy 5Gy x 5 days	Etiquetas MSS/ MMRp
NCT ID NCT04117087	TitlePooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer	Fase Fase 1	Date Added 2019-10-07	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, Nivolumab, Opdivo, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT04110093	TitleRegorafenib más inhibidor de PD-1 en pacientes con cáncer colorrectal	Fase Fase 1/Fase 2	Date Added 2019-10-01	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Regorafenib e inhibidor de PD-1	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04111172	TitleUna vacuna (Ad5.F35-hGCC-PADRE) para el tratamiento del adenocarcinoma gastrointestinal	Fase Fase 2	Date Added 2019-10-01	Ubicación Pennsylvania, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04111458	TitleA Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)	Fase Fase 1	Date Added 2019-10-01	Ubicación Massachusetts, United States North Carolina, United States Tennessee, United States Texas, United States Alemania Países Bajos	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas BI 1701963, Trametinib	Etiquetas MSS/ MMRp
NCT ID NCT04104776	TitleUn estudio de CPI-0209 en pacientes con tumores sólidos y linfomas avanzados	Fase Fase 1	Date Added 2019-09-26	Ubicación Georgia, United States Illinois, United States Maryland, United States Massachusetts, United States Michigan, United States New Jersey, United States New York, United States Ohio, United States Texas, United States Virginia, United States Washington, United States Francia Italia Corea, República de Polonia España Reino Unido	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas CPI-0209, CPI-0209	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 161 to 170 of 299 entries